4.5 Review

Potential therapeutic targets of Guggulsterone in cancer

Journal

NUTRITION & METABOLISM
Volume 14, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/s12986-017-0180-8

Keywords

Natural compounds; Guggulsterone; Cancers; Chemoprevention; Molecular targets

Funding

  1. Medical Research Center [16354/16]
  2. Hamad Medical Corporation, Doha, and State of Qatar

Ask authors/readers for more resources

Natural compounds capable of inducing apoptosis in cancer cells have always been of considerable interest as potential anti-cancer agents. Many such compounds are under screening and development with their potential evolution as a clinical drug benefiting many of the cancer patients. Guggulsterone (GS), a phytosterol isolated gum resin of the tree Commiphora mukul has been widely used in Indian traditional medicine as a remedy for various diseses. GS has been shown to possess cancer chemopreventive and therapeutic potential as established by in vitro and in vivo studies. GS has been shown to target constitutively activated survival pathways such as PI3-kinase/AKT, JAK/STAT, and NFkB signaling pathways that are involved in the regulation of growth and inflammatory responses via regulation of antiapoptotic and inflammatory genes. The current review focuses on the molecular targets of GS, cellular responses, and the animal model studies in various cancers. The mechanistic action of GS in different types of cancers also forms a part of this review. The perspective of translating this natural compound into a clinically approved drug with its pros and cons is also discussed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Surgery

Mini-Open Carpal Tunnel Release in Carpal Tunnel Syndrome

Muzaffar Ahmad Malla, Mir Samiullah, Ajaz Ahmad Bhat, Munir Farooq

Summary: The present study evaluated the mini-open carpal tunnel release surgery on 25 patients and found significant improvement in symptom severity scores and functional status scores. The average sensory conduction velocity increased at 6 months postoperative, and there were very few complications.

INDIAN JOURNAL OF SURGERY (2023)

Review Chemistry, Multidisciplinary

Applications of polydopaminic nanomaterials in mucosal drug delivery

Takwa Bedhiafi, Sourour Idoudi, Areej Ali Alhams, Queenie Fernandes, Heba Iqbal, Renuka Basineni, Shahab Uddin, Said Dermime, Maysaloun Merhi, Nashiru Billa

Summary: Polydopamine (PDA) is a biopolymer with unique physicochemical properties and has various applications in drug delivery, biosensing, imaging, and cancer therapy. Recent research has discovered the potential of PDA as a coating material for mucosal drug delivery, but there is limited information on this application. This review presents the properties of PDA and its biomedical applications, with a focus on its role as a coating material for nanoparticulate carriers in mucosal drug delivery. The challenges and possibilities of translating this technology to clinical studies are also discussed.

JOURNAL OF CONTROLLED RELEASE (2023)

Article Biochemistry & Molecular Biology

Network-based identification and prioritization of key transcriptional factors of diabetic kidney disease

Ikhlak Ahmed, Mubarak Ziab, Sahar Da'as, Waseem Hasan, Sujitha P. Jeya, Elbay Aliyev, Sabah Nisar, Ajaz A. Bhat, Khalid Adnan Fakhro, Ammira S. Alshabeeb Akil

Summary: Diabetic nephropathy (DN) is a common microvascular complication of diabetes that leads to end-stage renal disease. This study aimed to identify key transcription factors (TFs) associated with DN progression by performing a meta-analysis on gene expression profiles from multiple datasets. The analysis revealed distinct clusters of dysregulated susceptibility genes in different renal compartments, with a subset of these genes encoding critical TFs involved in DN development and podocyte function. The role of these TFs was validated in a hyperglycemic zebrafish model, showing that altered expression of these genes leads to morphological abnormalities in various kidney structures. This study provides insights into the molecular drivers, essential genes, and pathways involved in DN initiation and development.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2023)

Review Multidisciplinary Sciences

The role of dietary antioxidants in type 2 diabetes and neurodegenerative disorders: An assessment of the benefit profile

Munazza Tamkeen Fatima, Ajaz Ahmad Bhat, Sabah Nisar, Khalid Adnan Fakhro, Ammira Sarah Al-Shabeeb Akil

Summary: A healthy diet is crucial for cellular health and oxidative stress plays a significant role in various diseases. Antioxidants, found in dietary foods such as tea, coffee, wine, oils, and honey, can reduce oxidative stress and combat type 2 diabetes and neurodegenerative disorders.

HELIYON (2023)

Review Medicine, Research & Experimental

Integrative toxicogenomics: Advancing precision medicine and toxicology through artificial intelligence and OMICs technology

Ajay Vikram Singh, Vaisali Chandrasekar, Namuna Paudel, Peter Laux, Andreas Luch, Donato Gemmati, Veronica Tisato, Kirti S. Prabhu, Shahab Uddin, Sarada Prasad Dakua

Summary: More information about genetic makeup, drug response, multi-omics response, and genomic response is now available, leading to personalized treatment. Non-animal testing and computational toxicogenomics are becoming integral parts of risk assessment. Artificial intelligence (AI) has the potential to analyze patient data, predict treatment outcomes, and expedite data processing in personalized medicine and toxicogenomics. This article explores the current trends, future perspectives, challenges, and limitations in personalized medicine, toxicogenomics, and AI.

BIOMEDICINE & PHARMACOTHERAPY (2023)

Review Pathology

Multiple myeloma and its rare paraneoplastic manifestations simmering under the surface

Sehrish Sarwar Baloch, Saqib Raza Khan, Muhammad Tariq, Abdul Wasio, Ayesha Arshad Ali, Mehwish Shahzadi, Munira Moosajee, Shaheena Anwar, Afsheen Raza, Shahab Uddin

Summary: Paraneoplastic syndromes are complex clinical manifestations caused by hormones, cytokines, peptides or antibodies produced by malignant cells in the underlying malignancy, affecting multiple organ systems. Multiple Myeloma (MM), accounting for 10-15% of hematological malignancies and 1-2% of all malignancies, is associated with atypical clinical and laboratory paraneoplastic manifestations. Understanding these manifestations is important for differential diagnosis in uncertain cases.

PATHOLOGY RESEARCH AND PRACTICE (2023)

Article Oncology

Epigenetic programing of cancer stemness by transcription factors-non-coding RNAs interactions

Reem Khaled M. E. Alsayed, Khalid Sultan A. M. Sheikhan, Majid Ali Alam, Jorg Buddenkotte, Martin Steinhoff, Shahab Uddin, Aamir Ahmad

Summary: Cancer 'stemness' is crucial for the existence and characteristics of cancer cells. Transcription factors such as NF-KB and STAT-3 play a significant role in cancer stemness and are potential targets for cancer therapy. The study of non-coding RNAs has revealed their interactions with these transcription factors, offering insights into the regulatory mechanisms of cancer stemness and potential therapeutic opportunities.

SEMINARS IN CANCER BIOLOGY (2023)

Review Cell & Tissue Engineering

Unveiling the Therapeutic Potential of Non-Coding RNAs in Stroke-Induced Tissue Regeneration

Arshi Waseem, Abdul Quaiyoom Khan, Mohsin Ali Khan, Rehan Khan, Shahab Uddin, Johannes Boltze, Syed Shadab Raza

Summary: Stroke is a leading cause of death and disability worldwide, but effective treatments are limited. Abnormal expression of various non-coding RNAs (ncRNAs) has been found after stroke, affecting processes such as neurogenesis, angiogenesis, apoptosis, and autophagy. Understanding the roles and mechanisms of ncRNAs holds promise for future stroke treatments, as they can modify the impact and progression of stroke on a molecular level. Exploring the functions and underlying mechanisms of ncRNAs after stroke may reveal new therapeutic targets and improve diagnostics for stroke.

STEM CELLS (2023)

Article Multidisciplinary Sciences

The odd lindley power rayleigh distribution: properties, classical and bayesian estimation with applications

A. . A. . Bhat, Sheikh P. Ahmad, Ehab M. Almetwally, Nagla Yehia, Najwan Alsadat, Ahlam H. Tolba

Summary: In this paper, the authors propose and investigate the odd Lindley Power Rayleigh (OLPR) distribution, which combines the odd Lindley-G family and power Rayleigh distribution. The proposed distribution offers greater flexibility than some well-known extensions, such as the Lindley and Rayleigh distributions. The paper provides a comprehensive analysis of the mathematical and statistical properties of the OLPR distribution, as well as estimation methods using classical and Bayesian approaches. Additionally, the authors conduct a simulation study to assess the performance of estimators based on biases and mean square errors, and demonstrate the superiority of the proposed model in practical real-life applications using various goodness-of-fit measures.

SCIENTIFIC AFRICAN (2023)

Article Oncology

Epigenetic modifications: Key players in cancer heterogeneity and drug resistance

Hana Q. Sadida, Alanoud Abdulla, Sara Al Marzooqi, Sheema Hashem, Muzafar A. Macha, Ammira S. Al-Shabeeb Akil, Ajaz A. Bhat

Summary: Cancer heterogeneity and drug resistance are major obstacles to effective cancer treatment, and epigenetic modifications play a pivotal role in these processes. This review explores essential epigenetic modifications, including DNA methylation, histone modifications, and chromatin remodeling, and discusses their complex contributions to cancer biology. However, the interplay of epigenetic and genetic changes in cancer cells presents unique challenges that must be addressed to fully exploit the potential of epigenetic modifications.

TRANSLATIONAL ONCOLOGY (2024)

Article Cell Biology

Role of HMGB1 and its associated signaling pathways in human malignancies

Sourour Idoudi, Takwa Bedhiafi, Shona Pedersen, Mohamed Elahtem, Izzaldin Alremawi, Sabah Akhtar, Said Dermime, Maysaloun Merhi, Shahab Uddin

Summary: This review focuses on the role of HMGB1 in human malignancies and the signaling pathways associated with it. It also discusses the potential of HMGB1 as a target/biomarker for cancer therapy, as well as the therapeutic strategies used to target HMGB1.

CELLULAR SIGNALLING (2023)

Article Pharmacology & Pharmacy

Shrinking the battlefield in cancer therapy: Nanotechnology against cancer stem cells

Queenie Fernandes, Lubna Therachiyil, Abdul Q. Khan, Takwa Bedhiafi, Hesham M. Korashy, Ajaz A. Bhat, Shahab Uddin

Summary: Cancer is a major cause of death worldwide and current treatments have limited efficacy. Nanotechnology offers innovative solutions by leveraging the unique properties of nanomaterials, improving drug efficiency, reducing side effects, and targeting cancer stem cells. However, there are still challenges in obtaining clinical approval for nano-drugs.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2023)

Review Oncology

The role of LncRNA MCM3AP-AS1 in human cancer

Shirin Azizidoost, Farhoodeh Ghaedrahmati, Mohadeseh Sheykhi-Sabzehpoush, Shahab Uddin, Mehri Ghafourian, Abdolah Mousavi Salehi, Mona Keivan, Maryam Cheraghzadeh, Zahra Nazeri, Maryam Farzaneh, Seyed Esmaeil Khoshnam

Summary: MCM3AP-AS1, a long noncoding RNA, is implicated in the progression of several types of cancers by targeting various signaling pathways and microRNAs associated with cancer development.

CLINICAL & TRANSLATIONAL ONCOLOGY (2023)

No Data Available